Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report

BACKGROUND: Targeted therapy with tyrosine kinase inhibitors has been shown to reduce tumor volumes and prolong the survival of patients with metastatic renal cell carcinoma. Tyrosine kinase inhibitors, particularly sunitinib, have recently been used in neoadjuvant and presurgical settings. Axitinib...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Res Notes
Hlavní autoři: Koie, Takuya, Ohyama, Chikara, Okamoto, Akiko, Yamamoto, Hayato, Imai, Atsushi, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4222084/
https://ncbi.nlm.nih.gov/pubmed/24267160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-6-484
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky